Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft Clinical Trials

Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft

Explore clinical trials studying Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft trial results

Completed

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

NCT01056822

Conditions: Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft
Locations: Novartis Investigative Site Granada, Andalusia, Spain

Novartis Investigative Site Palma de Mallorca, Balearic Islands, Spain

Novartis Investigative Site Barakaldo, Basque Country, Spain

Novartis Investigative Site Santander, Cantabria, Spain

View all 19 locations

View Trial Details